Barriers to the use of long-acting injectable antipsychotics in schizophrenia may be overcome by implementing a variety of strategies
Crossref DOI link: https://doi.org/10.1007/s40267-016-0345-y
Published Online: 2016-09-02
Published Print: 2017-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
,
License valid from 2016-09-02